Roche Holding AG

RHO5

Company Profile

  • Business description

    Roche is a Swiss biopharmaceutical and diagnostic company. The firm's bestselling pharmaceutical products include a variety of oncology therapies from acquired partner Genentech, and its diagnostics group was bolstered by the acquisition of Ventana in 2008. Oncology products account for 50% of pharmaceutical sales, and centralized and point-of-care diagnostics for more than half of diagnostic-related sales.

  • Contact

    Grenzacherstrasse 124
    Basel4070
    CHE

    T: +41 616881111

    E: [email protected]

    https://www.roche.com

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Drug Manufacturers - General

    Fiscal Year End

    31 December 2025

    Employees

    103,249

Stocks News & Analysis

stocks

Magnificent Seven vs. the ‘Granolas’: How does Europe’s version stack up?

‘Granolas’ stocks are profitable, diversified, cheap—and posting big returns.

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries8,013.708.20-0.10%
CAC 407,320.2334.370.47%
DAX 4021,278.6872.820.34%
Dow JONES (US)38,967.93797.522.09%
FTSE 1008,331.2855.620.67%
HKSE21,562.32167.180.78%
NASDAQ16,249.44378.542.39%
Nikkei 22534,220.6059.32-0.17%
NZX 50 Index11,836.69282.30-2.33%
S&P 5005,266.33108.132.10%
S&P/ASX 2007,816.702.40-0.03%
SSE Composite Index3,299.768.320.25%

Market Movers